Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

SynAct Pharma

17.42 SEK

-0.57 %

Less than 1K followers

SYNACT

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for SynAct Pharma

2019202020212022202320242025
Revenue
growth-%
EBITDA-23.7-31.0-76.7-105.7-224.5-90.0-
EBIT-24.1-31.3-76.7-105.7-224.5-90.0-116.5
Profit before taxes-27.1-31.3-76.8-107.1-224.3-90.8-119.0
Net income-24.0-26.6-69.3-99.2-215.8-82.4-110.8
EPS-1.61-1.07-2.64-3.57-6.58-2.08-2.17
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %
Login required

This content is only available for logged in users

Create account

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-177.4 %-167.3 %-332.1 %-78.4 %-122.5 %-38.5 %-65.1 %
ROI-100.6 %-123.0 %-180.6 %-69.6 %-94.6 %-30.5 %-50.3 %
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.